{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T16:06:55Z","timestamp":1793290015997,"version":"4.5.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014349","name":"Society For Maternal-Fetal Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["ajog.org","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["American Journal of Obstetrics and Gynecology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/j.ajog.2023.04.039","type":"journal-article","created":{"date-parts":[[2023,5,3]],"date-time":"2023-05-03T20:43:45Z","timestamp":1683146625000},"page":"B2-B9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement"],"prefix":"10.1016","volume":"229","author":[{"given":"C. Andrew","family":"Combs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha R.","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie L.","family":"Morgan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ajog.2023.04.039_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.15585\/mmwr.mm7117a1","article-title":"Hypertensive disorders in pregnancy and mortality at delivery hospitalization - United States, 2017-2019","volume":"71","author":"Ford","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/j.ajog.2023.04.039_bib2","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(16)31470-2","article-title":"GBD 2015 Maternal Mortality Collaborators. Global, regional, and national levels of maternal mortality, 1990-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.039_bib3","doi-asserted-by":"crossref","first-page":"405.e1","DOI":"10.1016\/j.ajog.2018.07.002","article-title":"Contribution of hypertension to severe maternal morbidity","volume":"219","author":"Hitti","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib4","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1111\/ajo.12971","article-title":"Pre-eclampsia causing severe maternal morbidity - a national retrospective review of preventability and opportunities for improved care","volume":"59","author":"MacDonald","year":"2019","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib5","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1080\/10641955.2016.1190846","article-title":"Preeclampsia and preterm delivery: a population-based case-control study","volume":"35","author":"Davies","year":"2016","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/j.ajog.2023.04.039_bib6","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(16)31575-6","article-title":"Global, regional, national, and selected subnational levels of stillbirths, neonatal, infant, and under-5 mortality, 1980-2015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/j.ajog.2023.04.039_bib7","doi-asserted-by":"crossref","first-page":"f6564","DOI":"10.1136\/bmj.f6564","article-title":"Pre-eclampsia rates in the United States, 1980-2010: age-period-cohort analysis","volume":"347","author":"Ananth","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/j.ajog.2023.04.039_bib8","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ajog.2016.09.076","article-title":"The role of aspirin dose on the prevention of preeclampsia and fetal growth restriction: systematic review and meta-analysis","volume":"216","author":"Roberge","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib9","doi-asserted-by":"crossref","first-page":"e31","DOI":"10.1016\/j.amepre.2021.01.032","article-title":"Aspirin prophylaxis during pregnancy: a systematic review and meta-analysis","volume":"61","author":"Choi","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/j.ajog.2023.04.039_bib10","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1001\/jama.2021.8551","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: updated evidence report and systematic review for the US Preventive Services Task Force","volume":"326","author":"Henderson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.04.039_bib11","doi-asserted-by":"crossref","first-page":"S1108","DOI":"10.1016\/j.ajog.2020.08.045","article-title":"Prevention of preeclampsia with aspirin","volume":"226","author":"Rolnik","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib12","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1056\/NEJMra2109523","volume":"386","author":"Magee","year":"2022","journal-title":"Preeclampsia. N Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.039_bib13","doi-asserted-by":"crossref","first-page":"1186","DOI":"10.1001\/jama.2021.14781","article-title":"Aspirin use to prevent preeclampsia and related morbidity and mortality: US Preventive Services Task Force recommendation statement","volume":"326","author":"Davidson","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.04.039_bib14","author":"Bryant"},{"key":"10.1016\/j.ajog.2023.04.039_bib15","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1016\/j.jogc.2017.04.040","article-title":"Low rates of aspirin use for the prevention of preeclampsia","volume":"39","author":"Viguiliouk","year":"2017","journal-title":"J\u00a0Obstet Gynaecol Can"},{"key":"10.1016\/j.ajog.2023.04.039_bib16","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1002\/uog.19039","article-title":"Comparison of diagnostic accuracy of early screening for pre-eclampsia by NICE guidelines and a method combining maternal factors and biomarkers: results of SPREE","volume":"51","author":"Tan","year":"2018","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib17","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1111\/aogs.13808","article-title":"Low-dose-aspirin usage among women with an increased preeclampsia risk: a prospective cohort study","volume":"99","author":"Van Montfort","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/j.ajog.2023.04.039_bib18","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.30804","article-title":"Use of a smartphone app to explore potential underuse of prophylactic aspirin for preeclampsia","volume":"4","author":"Krishnamurti","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/j.ajog.2023.04.039_bib19","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1001\/jama.2021.22749","article-title":"DOH-NET (Diabetes, Obesity, and Hypertension in Pregnancy Research Network). Aspirin use for preeclampsia prevention among women with prepregnancy diabetes, obesity, and hypertension","volume":"327","author":"Ray","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/j.ajog.2023.04.039_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100663","article-title":"Assessment of adherence to aspirin for preeclampsia prophylaxis and reasons for nonadherence","volume":"4","author":"Olson","year":"2022","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/j.ajog.2023.04.039_bib21","doi-asserted-by":"crossref","DOI":"10.1007\/s00404-022-06773-0","article-title":"Relationship between risk factor profile and prescription of low-dose aspirin for preeclampsia prevention","author":"Phelps","year":"2022","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/j.ajog.2023.04.039_bib22","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1016\/j.ajog.2022.11.1302","article-title":"Association of checklist usage with adherence to recommended prophylactic low-dose aspirin for prevention of preeclampsia","volume":"228","author":"Zhou","year":"2023","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib23","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.1353\/hpu.2020.0123","article-title":"Preeclampsia risk and prevention among pregnant Medicaid beneficiaries","volume":"31","author":"Cross-Barnet","year":"2020","journal-title":"J\u00a0Health Care Poor Underserved"},{"key":"10.1016\/j.ajog.2023.04.039_bib24","article-title":"Assessment of racial disparities in aspirin prophylaxis for preeclampsia prevention","author":"Ragunanthan","year":"2022","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.04.039_bib25","article-title":"Quality improvement initiative for aspirin screening and prescription rates for preeclampsia prevention in an outpatient obstetric clinic","author":"Kumar","year":"2022","journal-title":"Am J Perinatol"},{"key":"10.1016\/j.ajog.2023.04.039_bib26","doi-asserted-by":"crossref","first-page":"B2","DOI":"10.1016\/j.ajog.2017.07.018","article-title":"Quality measures in high-risk pregnancies: executive summary of a Cooperative Workshop of the Society for Maternal-Fetal Medicine, National Institute of Child Health and Human Development, and the American College of Obstetricians and Gynecologists","volume":"217","author":"Iriye","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib27","doi-asserted-by":"crossref","first-page":"685.e1","DOI":"10.1016\/j.ajog.2017.08.110","article-title":"Aspirin for evidence-based preeclampsia prevention trial: influence of compliance on beneficial effect of aspirin in prevention of preterm preeclampsia","volume":"217","author":"Wright","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1161\/HYPERTENSIONAHA.119.14107","article-title":"Clinical influence of nonadherence with prophylactic aspirin in preventing preeclampsia in high-risk pregnancies: a multicenter, prospective, observational cohort study","volume":"75","author":"Shanmugalingam","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.04.039_bib29","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ejogrb.2017.10.004","article-title":"How important is\u00a0aspirin adherence when evaluating effectiveness of low-dose aspirin?","volume":"219","author":"Navaratnam","year":"2017","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.04.039_bib30","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.ejogrb.2020.11.058","article-title":"Assessing measures of aspirin adherence in pregnancy: secondary analysis of the TEST randomized controlled trial","volume":"259","author":"Mone","year":"2021","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/j.ajog.2023.04.039_bib33","doi-asserted-by":"crossref","first-page":"B7","DOI":"10.1016\/j.ajog.2020.06.003","article-title":"Society for Maternal-Fetal Medicine special statement: checklists for preeclampsia risk-factor screening to guide recommendations for prophylactic low-dose aspirin","volume":"223","author":"Combs","year":"2020","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib34","first-page":"560","article-title":"Can we make grand rounds \u201cgrand\u201d again?","volume":"5","author":"Sandal","year":"2013","journal-title":"J\u00a0Grad Med Educ"},{"key":"10.1016\/j.ajog.2023.04.039_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.jemermed.2014.09.010","article-title":"Not another boring lecture: engaging learners with active learning techniques","volume":"48","author":"Wolff","year":"2015","journal-title":"J\u00a0Emerg Med"},{"key":"10.1016\/j.ajog.2023.04.039_bib36","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1056\/NEJMp1706474","article-title":"Saying goodbye to lectures in medical school - paradigm shift or passing fad?","volume":"377","author":"Schwartzstein","year":"2017","journal-title":"N\u00a0Engl J Med"},{"key":"10.1016\/j.ajog.2023.04.039_bib37","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12909-019-1799-0","article-title":"Comparison of the effectiveness of\u00a0lectures based on problems and traditional lectures in physiology teaching in Sudan","volume":"19","author":"Alaagib","year":"2019","journal-title":"BMC Med Educ"},{"key":"10.1016\/j.ajog.2023.04.039_bib38","first-page":"299","article-title":"Impact of educational preeclampsia prevention booklet on knowledge and adherence to low dose aspirin among pregnant women with high risk for preeclampsia","volume":"30","author":"Karunia","year":"2020","journal-title":"J\u00a0Basic Clin Physiol Pharmacol"},{"key":"10.1016\/j.ajog.2023.04.039_bib39","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.preghy.2021.06.006","article-title":"Informational needs related to aspirin prophylactic therapy amongst pregnant women at risk of preeclampsia - a qualitative study","volume":"25","author":"Vinogradov","year":"2021","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/j.ajog.2023.04.039_bib40","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0229622","article-title":"Factors that influence adherence to aspirin therapy in the prevention of preeclampsia amongst high-risk pregnant women: a mixed method analysis","volume":"15","author":"Shanmugalingam","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/j.ajog.2023.04.039_bib41","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1080\/21642850.2021.1951273","article-title":"Aspirin non-adherence in pregnant women at risk of preeclampsia (ANA): a qualitative study","volume":"9","author":"Vinogradov","year":"2021","journal-title":"Health Psychol Behav Med"},{"key":"10.1016\/j.ajog.2023.04.039_bib42","doi-asserted-by":"crossref","first-page":"1242","DOI":"10.1097\/AOG.0000000000001115","article-title":"A\u00a0cost-benefit analysis of low-dose aspirin prophylaxis for the prevention of preeclampsia in the United States","volume":"126","author":"Werner","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/AOG.0000000000003413","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"134","author":"Mallampati","year":"2019","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib44","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1161\/HYPERTENSIONAHA.118.11718","article-title":"Preeclampsia prevention using routine versus screening test-indicated aspirin in low-risk women","volume":"72","author":"Mone","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/j.ajog.2023.04.039_bib45","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1097\/AOG.0000000000003631","article-title":"Strategies for prescribing aspirin to prevent preeclampsia: a cost-effectiveness analysis","volume":"135","author":"Cuckle","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib46","doi-asserted-by":"crossref","first-page":"S1120","DOI":"10.1016\/j.ajog.2021.10.038","article-title":"When to give aspirin to prevent preeclampsia: application of Bayesian decision theory","volume":"226","author":"Wright","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/j.ajog.2023.04.039_bib47","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022056","article-title":"Trial of feasibility and acceptability of routine low-dose aspirin versus Early Screening Test indicated aspirin for pre-eclampsia prevention (TEST study): a multicentre randomised controlled trial","volume":"8","author":"Mone","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/j.ajog.2023.04.039_bib48","doi-asserted-by":"crossref","first-page":"95.e1","DOI":"10.1016\/j.ajog.2020.07.023","article-title":"Aspirin use during pregnancy and the risk of bleeding complications: a Swedish population-based cohort study","volume":"224","author":"Hastie","year":"2021","journal-title":"Am J Obstet Gynecol"}],"container-title":["American Journal of Obstetrics and Gynecology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002937823002776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T11:43:45Z","timestamp":1757591025000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002937823002776"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,8]]},"references-count":46,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S0002937823002776"],"URL":"https:\/\/doi.org\/10.1016\/j.ajog.2023.04.039","relation":{},"ISSN":["0002-9378"],"issn-type":[{"value":"0002-9378","type":"print"}],"subject":[],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Society for Maternal-Fetal Medicine Special Statement: Prophylactic low-dose aspirin for preeclampsia prevention\u2014quality metric and opportunities for quality improvement","name":"articletitle","label":"Article Title"},{"value":"American Journal of Obstetrics and Gynecology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ajog.2023.04.039","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}